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Introduction {#sec001}
============

Disability is defined by the International Classification of Functioning, Disability and Health as the state of having limitations in body functions, structures, activities, and participation \[[@pone.0236665.ref001]\]. According to the National Disability Registry (NDR) of Korea, over 2.4 million individuals were registered as people with disability, which accounted for 5% of the Korean population \[[@pone.0236665.ref002]\].

Despite the importance of health in people with disabilities, they have received little attention within the health care system \[[@pone.0236665.ref003], [@pone.0236665.ref004]\]. A previous study in Korea showed that people with disability were more likely to be physically inactive, have higher incidence of osteoporosis, to be underweight, have suicidal thoughts, and have impaired quality of life \[[@pone.0236665.ref005]\]. Several studies in western countries also showed that people with disability often have adverse health behaviors (i.e., cigarette smoking, at-risk alcohol drinking, physical inactivity, and unhealthy diet) \[[@pone.0236665.ref006]--[@pone.0236665.ref011]\], receive fewer preventive health care services (i.e., cancer screening and vaccination) \[[@pone.0236665.ref012]--[@pone.0236665.ref016]\], and have chronic diseases \[[@pone.0236665.ref006], [@pone.0236665.ref017]--[@pone.0236665.ref020]\]. Furthermore, total and cardiovascular (CV) mortality increased in people with disability \[[@pone.0236665.ref021]--[@pone.0236665.ref025]\], and a study on elderly people aged \>80 years showed that disability exerts an important influence on mortality regardless of age and multimorbidity \[[@pone.0236665.ref026]\]. For this reason, we hypothesized that people with disability would show higher CV disease incidence and mortality owing to higher CV risk factors.

However, most previous studies that investigated the association between disability and mortality were small studies limited to a specific population or were focused only on a specific measure of disability such as physical capability measured by handgrip strength or gait speed. To our knowledge, there is no large longitudinal general population study evaluating the association between disability and CV disease incidence and mortality, especially in Asian countries.

This study aimed to examine the association between disability and CV disease incidence and mortality in Korea longitudinally, using a national representative sample.

Materials and methods {#sec002}
=====================

Study setting {#sec003}
-------------

The Korean National Health Insurance Service (KNHIS) is a public health insurance that provides universal health coverage to almost all Koreans, except Medicaid beneficiaries who account for \<3% of the Korean population. The KNHIS provides a National Screening Program (NSP), a biennial health screening program for all people aged \>40 years and all employees regardless of age. KNHIS created the National Health Information Database (NHID), which includes data on healthcare utilization, health screening results in NSP, sociodemographic variables, and mortality for over 50 million individuals in Korea \[[@pone.0236665.ref027]\]. The NHID has been widely used in various epidemiological and health policy studies, and details of the database profile are described elsewhere \[[@pone.0236665.ref027], [@pone.0236665.ref028]\].

Data sources and study population {#sec004}
---------------------------------

We used the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) database of NHID, in which 515,867 participants were included. This represents 10% of a randomly selected people from the total Korean participants aged 40--79 years who participated in the NSP at least once in 2002--2003. After excluding participants with missing data or who were misclassified, 514,679 were included in the present study.

The database included participants' demographic data (i.e., age, sex, residential area, and income status); disability information; survey data regarding past medical history and health behaviors; and screening results including height, weight, abdominal circumference, and laboratory tests. We also obtained data on medical facility utilization and the number of deaths.

The Asan Medical Center Institutional Review Board approved this study (IRB number: 2019--0563), and the requirement for informed consent was waived because the KNHIS database was constructed after anonymization according to strict confidentiality guidelines.

Variables {#sec005}
---------

### Independent variable {#sec006}

In this study, we used severity and type of disability as the independent variable, which is baseline characteristic at the time of NSP and time-invariant in our analysis model. The NHIS-HEALS dataset includes information on disability of NSP participants such as severity and type of disabilities, which were obtained from the Korean National Disability Registry. The severity of disability was divided into six grades, from 1 to 6. Grade 1 indicates extremely severe disability, while grade 6 indicates the least severe disability. In NHIS-HEALS dataset, grades 1 and 2 are categorized as "severe disability," while grades 3--6 as "mild disability." If participants have no disability grade, they are categorized as "normal," which indicates that they are persons without disability. The types of disability were divided into eight categories: physical impairment, brain impairment, visual impairment, hearing impairment, linguistic impairment, mental impairment, and others (i.e., developmental disability, renal function impairment, heart function impairment, respiratory function impairment, liver function impairment, facial deformity, intestinal and urinary tract function impairment, and epilepsy). The definition of type of disability as following: physical impairment is disability related to amputation, motor disturbance, joint disability, deformity of limbs, or spinal cord injury. Brain impairment is related to brain disability caused by stroke, brain damage, or cerebral palsy. Visual impairment is related to visual loss or visual field defect, and hearing impairment is related to hearing disability or disability in sense of equilibrium. Linguistic impairment is related to mogilalia or dysphonia. Mental impairment is mental illness with limitation of daily life such as depression or schizophrenia, which is different from mental retardation that means intelligence quotient \< 70. Because there were only small number of participants except physical impairment, we aggregated type of disability as following: physical, sensory (visual impairment + hearing impairment), neuropsychological (brain impairment + linguistic impairment + mental impairment + mental retardation), and others.

### Outcome variables {#sec007}

CV event and mortality were outcome variables of this study. Data regarding the diagnosis of a CV event, the date of event, the cause of death, and date of death were obtained from the NHIS-HEALS database in 2002--2015. CV event or death was defined as event of or death caused by ischemic heart diseases (I20--25) or cerebrovascular disease (I60--69) during the follow-up period. If participants did not have the date of death, they were considered alive at the end of 2015. We assumed there is no right censoring other than death. Because all persons are supposed to be beneficiaries of the National Health Insurance in Korea, dropouts other than due to death are virtually impossible.

The follow-up time for CV disease was calculated as the time from the date of the NSP examination to the first diagnosis of CV disease, date of death, or the end of 2015, whichever comes first. And the follow-up time for CV mortality was calculated as the time from the date of the NSP examination to date of CV death, or the end of 2015, whichever comes first.

Potential confounders {#sec008}
---------------------

Potential confounders included data on health behavior, chronic diseases, and Body mass index (BMI), which are baseline characteristics at the time of NSP and time-invariant in our analysis model.

Data on health behavior were collected using a self-administered questionnaire at the time of NSP examination. In terms of smoking status, we categorized the respondents as current smokers, ex-smokers, or nonsmokers. An at-risk alcohol drinker was defined as a man \<65 years who drank more than 14 drinks per week or four drinks per occasion, or a man aged ≥65 years or a woman of any age who drank more than seven drinks per week or three drinks per occasion \[[@pone.0236665.ref029]\].

Data on chronic diseases such as hypertension, diabetes mellitus, and dyslipidemia were collected using the same questionnaire and laboratory results of NSP. If participants responded that they took medications for hypertension, diabetes mellitus, or dyslipidemia, they were considered to have the disease. If their systolic blood pressure was ≥140 mmHg or diastolic blood pressure was ≥ 90 mmHg, they were considered to have hypertension. If their serum fasting glucose level was ≥126 mg/dL, they were considered to have diabetes mellitus. If their serum total cholesterol level was ≥240 mg/dL, they were considered to have dyslipidemia.

BMI was calculated as weight divided by height in meters squared (kg/m^2^). We used Asian-specific criteria for BMI to define normal BMI. Normal BMI is defined as 18.5 and 23 kg/m^2^, underweight as \<18.5 kg/m^2^, and obese as BMI ≥ 25 kg/m^2^.

Statistical analysis {#sec009}
--------------------

Baseline characteristics are expressed as frequencies and percentages. We hypothesized that people with disability would show increased CV event and mortality owing to higher CV risk factors such as sex, age, health behavior, and chronic disease status compared with people without disability \[[@pone.0236665.ref002], [@pone.0236665.ref005]\]. To test this hypothesis, we conducted a survival analysis and subgroup analysis according to CV risk factors. Cox proportional hazard models were used to evaluate the association between type or severity of disability, and CV event, CV death, or all-cause death.

In the survival analyses, we built four different models. In addition to crude model, Model 1 was adjusted for sex and age. In Model 2, hypertension, diabetes mellitus, and dyslipidemia were added to Model 1. In Model 3, cigarette smoking, at-risk alcohol drinking, and BMI were added to Model 2. We calculated the hazard ratio and 95% confidence interval (CI) for each model.

We conducted subgroup analyses. First, we performed a survival analysis according to sex and age group and then according to behavioral factors such as cigarette smoking; alcohol drinking; and chronic diseases such as hypertension, diabetes mellitus, and dyslipidemia. Furthermore, we conducted a survival analysis according to aggregated type of disability. For subgroup analysis, we used the model without variable of stratification. For example, we used model 1 without sex in model 1 of subgroup analysis for sex (i.e. the model 1 in subgroup analysis for sex was adjusted only for age). Statistical analyses were performed using STATA software (version 16.1; STATA. Corp, College Station, Texas). A P-value of \<0.05 was considered significant.

Results {#sec010}
=======

Basal characteristics of participants {#sec011}
-------------------------------------

The mean follow-up duration was 10.8 ± 3.9 years (maximum, 13.9 years). At the end of 2015, 47,514 participants (9.2%) died. Of the deceased participants, 7,317 (1.4%) died of CV disease. In 5,572,130 person-year (PY) follow-up, the CV mortality rate was 1.313 per 1,000 PY.

Among the 514,679 participants included in the analysis, 445 (0.09%) had mild disability and 1,561 (0.30%) had severe disability. Approximately 45% of the participants were women, and the number of men with disability was higher than that of women. About 44% of total study participants were aged \<50 years, while about 30% of them were aged ≥65 years. Participants with disabilities were older than those without disabilities. Over 60% of the participants had normal baseline body weight, while one-third were overweight. Two-thirds of the participants declared that they never smoked, while 23% of them answered that they smoked. The proportions of participants with disabilities who are current smokers were lesser than that of participants without disabilities. In addition, one-third of the participants revealed that they were at-risk drinkers. Half of the participants answered that they had hypertension, 12% had diabetes mellitus, and 16% had dyslipidemia ([Table 1](#pone.0236665.t001){ref-type="table"}).

10.1371/journal.pone.0236665.t001

###### Basic characteristics of participants.

![](pone.0236665.t001){#pone.0236665.t001g}

                              Total            Normal           Mild disabled   Severe disabled
  --------------------------- ---------------- ---------------- --------------- -----------------
  Sex (women) (%)             235,715 (45.8)   233,710 (45.9)   445 (31.3)      1,560 (36.1)
  Age (years)                                                                   
   \<50                       225,584 (43.8)   225,153 (44.2)   215 (15.1)      216 (5.0)
   50--64                     122,759 (23.9)   122,007 (24.0)   319 (22.5)      433 (10.0)
   ≥ 65                       166,336 (32.3)   161,773 (31.8)   887 (62.4)      3,676 (85.0)
  BMI (kg/m^2^)                                                                 
   Underweight (\<18.5)       12,489 (2.4)     12,267 (2.4)     75 (5.3)        147 (3.4)
   Normal weight (18.5--25)   323,147 (62.8)   319,642 (62.9)   936 (66.1)      2,569 (59.4)
   Overweight (≥25)           178,651 (34.7)   176,639 (34.7)   406 (28.9)      1,606 (37.2)
  Cigarette smoking                                                             
   Never                      329,827 (66.4)   326,137 (68.3)   944 (68.3)      2,746 (64.5)
   Ex--smoker                 54,006 (10.9)    53,023 (10.8)    199 (14.4)      784 (18.4)
   Current smoker             112,900 (22.7)   111,930 (22.8)   240 (17.4)      730 (17.1)
  At--risk alcohol drinking   71,686 (33.4)    71,221 (33.4)    140 (38.3)      325 (42.8)
  Hypertension                287,211 (55.8)   283,234 (55.7)   971 (68.4)      3,016 (69.7)
  Diabetes mellitus           64,008 (12.4)    62,743 (12.3)    346 (24.4)      919 (21.3)
  Dyslipidemia                81,303 (15.8)    80,253 (15.8)    231 (16.3)      819 (19.0)
  Cardiovascular event        3,778 (0.7)      3654 (0.7)       38 (2.7)        86 (2.0)
  Cardiovascular death        7,317 (1.4)      7066 (1.4)       110 (7.7)       141 (3.3)
  All-cause death             47,514 (9.2)     46,345 (9.1)     489 (34.4)      680 (15.7)

\*Mild disabled: disability grades 3--6

\*\*Severe disability: disability grades 1--2

Cardiovascular incidence, mortality, all-cause mortality rate according to type of disability {#sec012}
---------------------------------------------------------------------------------------------

A quarter of mild disabled and a half of severe disabled participants were physically impaired. Physical impairment was the most common type of disability in both mild and severe disabled groups in both sexes, except in women with mild disability, followed by visual and hearing impairments ([Table 2](#pone.0236665.t002){ref-type="table"}).

10.1371/journal.pone.0236665.t002

###### Proportion of participants by types of disability.

![](pone.0236665.t002){#pone.0236665.t002g}

  Type of disability      Mild disabled (N = 1,421)   Severe disabled (N = 4,325)                   
  ----------------------- --------------------------- ----------------------------- --------------- -------------
  Physical impairment     249 (25.5%)                 93 (20.9%)                    1,365 (46.4%)   885 (56.7%)
  Brain impairment        137 (14.0%)                 57 (12.8%)                    235 (8.5%)      105 (6.7%)
  Visual impairment       103 (10.6%)                 93 (21.1%)                    389 (14.1%)     222 (14.2%)
  Hearing impairment      159 (16.3%)                 74 (16.6%)                    376 (13.6%)     188 (12.1%)
  Linguistic impairment   66 (6.8%)                   18 (4.0%)                     155 (5.6%)      50 (3.2%)
  Mental retardation      69 (7.1%)                   39 (8.8%)                     62 (2.2%)       21 (1.4%)
  Mental impairment       50 (5.1%)                   26 (5.8%)                     27 (1.0%)       21 (1.4%)
  Others                  143 (14.7%)                 45 (10.1%)                    156 (5.6%)      68 (4.4%)

Among the type of disability, physically impaired participants showed the highest CV disease incidence and mortality rate in both mild and severe disabled groups (incidence rate: 10.7 per 1,000 PY for mild disabled group and 14.5 per 1,000 PY for severe disabled group; mortality rate: 26.2 per 1,000 PY for mild disabled group and 10.8 per severe disabled group). CV disease incidence and mortality were lower in patients with other types of disabilities. CV disease incidence ranged from 0 to 3.6 per 1,000 PY, while CV mortality ranged from 2.5 to 8.2 per 1,000 PY ([Fig 1](#pone.0236665.g001){ref-type="fig"}).

![Cardiovascular disease incidence and mortality rate according to types of disability: A) Cardiovascular disease incidence. B) Cardiovascular mortality.](pone.0236665.g001){#pone.0236665.g001}

For aggregated types of disability, CV mortality, and all-cause mortality increased regardless of type of disability. The CV incidence and mortality were highest in neuropsychological disability, which contains person with previous stroke history. ([Table 3](#pone.0236665.t003){ref-type="table"}).

10.1371/journal.pone.0236665.t003

###### Cardiovascular disease and all-cause mortality according to type of disability.

![](pone.0236665.t003){#pone.0236665.t003g}

                         Disability   Number    Event       Duration (PY)   Incidence rate          aHR (95% CI)
  ---------------------- ------------ --------- ----------- --------------- ----------------------- --------------
  Cardiovascular event   All          514,679   3,778       5,572,226       0.679                   
  Normal                 508,933      3,654     5,538,403   0.660           Ref                     
  Disabled               5,746        124       33,823      3.784           2.890 (2.412--3.463)    
  Physical               2,592        24        10,895      2.203           1.418 (0.948--2.122)    
  Sensory                1,604        21        10,905      1.926           1.322 (0.860--2.033)    
  Neuropsychological     1,156        59        9,308       6.389           6.854 (5.270--8.913)    
  Others                 412          20        2,582       7.746           8.183 (5.207--12.857)   
  Cardiovascular death   All          514,679   7,317       5,572,341       1.313                   
  Normal                 508,933      7,066     5,538,518   1.275           Ref                     
  Disabled               5,746        251       33,823      7.421           2.030 (1.784--2.309)    
  Physical               2,592        80        10,895      7.343           1.704 (1.362--2.132)    
  Sensory                1,604        62        10,905      5.686           1.313 (1.020--1.691)    
  Neuropsychological     1,156        90        9,308       9.669           4.020 (3.252--4.670)    
  Others                 412          19        2,582       7.359           2.846 (1.791--4.521)    
  All--cause death       All          514,679   47,514      5,572,341       8.527                   
  Normal                 508,933      46,345    5,538,518   8.368           Ref                     
  Disabled               5,746        1,169     33,823      34.651          1.513 (1.426--1.607)    
  Physical               2,592        371       10,895      34.052          1.275 (1.149--1.414)    
  Sensory                1,604        340       10,905      31.179          1.161 (1.041--1.295)    
  Neuropsychological     1,156        301       9,308       32.339          2.065 (1.839--2.318)    
  Others                 412          157       2,582       60.805          3.608 (3.073--4.236)    

Adjusted for sex, age, hypertension, diabetes mellitus, dyslipidemia, BMI, cigarette smoking, at-risk drinking

Physical: physical impairment, Sensory: visual impairment + hearing impairment, Neuropsychological: brain impairment + linguistic impairment + mental impairment + mental retardation

N/A: not applicable due to high missing rate

Cardiovascular disease incidence and mortality according to severity of disability {#sec013}
----------------------------------------------------------------------------------

CV disease incidence was significantly higher in participants with disability than in those without disability in Models 1 and 2 for both mild and severe disabled groups. However, in Model 3, CV disease incidence was three to five times higher only among participants aged 50--64 years and severe disabled participants aged \<50 years. No significant difference was observed in participants aged ≥65 years. Furthermore, CV disease incidence increased in both sexes in Models 1 and 2 but not in Model 3.

Similarly, CV mortality was significantly higher in participants with disability than in those without disability in all Models. Compared with CV disease incidence, CV mortality was one and a half to six times higher in participants with disability in all age groups, except for those with severe disability aged \<50 years. Moreover, CV mortality increased in both sexes in Models 1 and 2 but in only men in Model 3 (Tables [4](#pone.0236665.t004){ref-type="table"} and [5](#pone.0236665.t005){ref-type="table"}).

10.1371/journal.pone.0236665.t004

###### Association between severity of disability and cardiovascular event.

![](pone.0236665.t004){#pone.0236665.t004g}

                      Disability   Number    Event       Duration (PY)   Incidence rate           Crude                  Model 1                Model 2                Model 3
  ------------------- ------------ --------- ----------- --------------- ------------------------ ---------------------- ---------------------- ---------------------- ---------
  Total               All          514,679   3,778       5,572,015       0.678                                                                                         
  Normal              508,933      3,654     5,538,329   0.660           Ref                      Ref                    Ref                    Ref                    
  Mild                1,421        38        11,821      3.214           6.297(4.574--8.670)      2.748(1.994--3.788)    2.758(2.001--3.800)    1.394(0.578--3.360)    
  Severe              4,325        86        21,864      3.933           7.945(6.413--9.843)      2.822(2.273--3.502)    2.868(2.311--3.560)    1.548(0.927--2.585)    
  Sex                                                                                                                                                                  
  Men                 All          278,694   2,496       3,023,064       0.826                                                                                         
  Normal              275,223      2,407     3,000,020   0.802           Ref                      Ref                    Ref                    Ref                    
  Mild                976          29        8,052       3.602           5.908 (4.095--8.523)     2.507 (1.736--3.620)   2.505 (1.734--3.617)   1.469 (0.609--3.542)   
  Severe              2,765        60        14,992      4.002           6.700 (5.183--8.661)     2.412 (1.862--3.124)   2.431 (1.876--3.148)   1.456 (0.840--2.524)   
  Women               All          235,715   1,282       2,548,951       0.503                                                                                         
  Normal              233,710      1,247     2,538,309   0.491           Ref                      Ref                    Ref                    Ref                    
  Mild                445          9         3,770       2.388           6.226 (3.231--11.996)    3.629 (1.882--6.995)   3.620 (1.878--6.979)   N/A                    
  Severe              1,560        26        6,873       3.783           10.466 (7.093--15.442)   4.279 (2.894--6.326)   4.408 (2.981--6.516)   2.359 (0.577--9.637)   
  Age                                                                                                                                                                  
  \<50                All          225,584   731         2,891,196       0.253                                                                                         
  Normal              225,153      726       2,885,839   0.252           Ref                      Ref                    Ref                    Ref                    
  Mild                215          2         2,638       0.758           3.826(0.955--15.329)     3.327(0.830--13.333)   3.267(0.815--13.097)   5.481(0.769--39.085)   
  Severe              216          3         2,718       1.104           4.359(1.402--13.547)     3.655(1.176--11.364)   3.567(1.147--11.091)   5.570(1.386--22.376)   
  50--64              All          122,759   1,149       1,490,664       0.771                                                                                         
  Normal              122,007      1,117     1,482,506   0.753           Ref                      Ref                    Ref                    Ref                    
  Mild                319          14        3,310       4.229           7.822(4.616--13.254)     6.033(3.557--10.232)   5.787(3.410--9.822)    4.590(1.469--14.343)   
  Severe              433          18        4,848       3.713           5.978(3.752--9.525)      4.498(2.819--7.176)    4.541(2.846--7.245)    3.349(1.248--8.991)    
  ≥ 65                All          166,336   1,898       1,190,155       1.595                                                                                         
  Normal              161,773      1,811     1,169,984   1.548           Ref                      Ref                    Ref                    Ref                    
  Mild                887          22        5,873       3.745           2.496(1.639--3.800)      2.232(1.465--3.401)    2.232(1.465--3.401)    0.411(0.058--2.926)    
  Severe              3,676        65        14,298      4.546           3.198(2.496--4.096)      2.916(2.273--3.741)    2.921(2.277--3.748)    1.396(0.720--2.705)    
  Health behavior                                                                                                                                                      
  Current smoker      All          112,900   810         1,287,568       0.628                                                                                         
  Normal              111,930      785       1,280,710   0.613           Ref                      Ref                    Ref                    Ref                    
  Mild                240          4         2,209       1.811           4.122(1.542--11.015)     1.904(0.712--5.094)    1.905(0.712--5.098)    1.776(0.442--7.139)    
  Severe              730          20        4,648       4.303           9.818(6.293--15.317)     3.236(2.063--5.077)    3.281(2.091--5.148)    2.675(1.372--5.213)    
  At-risk drinking    All          71,686    483         792,504         0.609                                                                                         
  Normal              71,221       473       788,162     0.600           Ref                      Ref                    Ref                    Ref                    
  Mild                140          4         1,367       2.927           6.207(2.319--16.615)     2.893(1.079--7.760)    2.867(1.069--7.688)    2.956(1.102--7.927)    
  Severe              325          6         2,976       2.016           4.250(1.899--9.514)      1.284(0.571--2.888)    1.312(0.583--2.952)    1.384(0.615--3.115)    
  Chronic disease                                                                                                                                                      
  Hypertension        All          287,221   2,631       2,953,790       0.891                                                                                         
  Normal              283,234      2,541     2,931,174   0.867           Ref                      Ref                    Ref                    Ref                    
  Mild                971          27        7,730       3.493           5.107(3.495--7.464)      2.711(1.853--3.965)    2.682(1.833--3.923)    0.749(0.187--3.001)    
  Severe              3,016        63        14,886      4.232           6.352(4.945--8.159)      2.762(2.146--3.555)    2.786(2.165--3.586)    1.313(0.701--2.457)    
  Diabetes mellitus   All          64,008    658         581,099         1.132                                                                                         
  Normal              62,743       628       574,878     1.092           Ref                      Ref                    Ref                    Ref                    
  Mild                346          12        2,485       4.828           5.103(2.882--9.037)      3.586(2.023--6.355)    3.592(2.207--6.366)    1.226(0.172--8.751)    
  Severe              919          18        3,736       4.818           5.688(3.556--9.098)      2.907(1.812--4.665)    2.936(1.829--4.712)    1.760(0.559--5.539)    
  Dyslipidemia        All          81,303    643         806,647         0.797                                                                                         
  Normal              80,253       623       801,370     0.777           Ref                      Ref                    Ref                    Ref                    
  Mild                231          8         1,851       4.322           7.118(3.542--14.306)     3.652(1.812--7.358)    3.589(1.781--7.232)    2.072(0.289--14.849)   
  Severe              819          12        3,427       3.502           5.825(3.286--10.323)     2.765(1.556--4.914)    2.827(1.591--5.026)    0.852(0.119--6.124)    

Model 1: sex and age

Model 2: Model 1 + hypertension, diabetes mellitus, and dyslipidemia

Model 3: Model 2 + body mass index, cigarette smoking, and at-risk alcohol drinking

For subgroup analysis, we used the model without variable of stratification. For example, we used model 1 without sex in model 1 of subgroup analysis for sex

N/A: not applicable due to high missing rate, CI: confidence interval, PY: person-year, HR: hazard ratio

10.1371/journal.pone.0236665.t005

###### Association between severity of disability and cardiovascular death.
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  Age                 Disability   Number    Death       Duration (PY)   Mortality rate           Crude                   Model 1                 Model 2                 Model 3
  ------------------- ------------ --------- ----------- --------------- ------------------------ ----------------------- ----------------------- ----------------------- ---------
  Total               All          514,679   7,317       5,572,130       1.313                                                                                            
  Normal              508,984      7,066     5,538,444   1.275           Ref                      Ref                     Ref                     Ref                     
  Mild                1,421        110       11,821      9.305           7.543 (6.248--9.106)     2.908 (2.407--3.513)    2.905 (2.403--3.512)    3.182 (2.217--4.567)    
  Severe              4,325        141       21,864      6.449           5.426 (4.592--6.411)     1.586 (1.341--1.876)    1.613 (1.364--1.907)    1.729 (1.285--2.327)    
  Sex                                                                                                                                                                     
  Men                 All          278,962   4,401       3,023,155       1.456                                                                                            
  Normal              275,223      4,213     3,000,112   1.404           Ref                      Ref                     Ref                     Ref                     
  Mild                976          84        8,052       10.432          7.618 (6.138--9.456)     3.011 (2.424--3.740)    3.032 (2.441--3.765)    3.402 (2.369--4.885)    
  Severe              2,765        106       14,992      7.071           5.316 (4.386--6.447)     1.688 (1.390--2.049)    1.717 (1.414--2.084)    1.718 (1.258--2.345)    
  Women               All          235,715   2,914       2,548,975       1.143                                                                                            
  Normal              233,710      2,853     2,538,332   1.124           Ref                      Ref                     Ref                     Ref                     
  Mild                445          26        3,770       6.897           6.384 (4.339--9.393)     2.927 (1.989--4.307)    2.810 (1.895--4.167)    N/A                     
  Severe              1,560        35        6,873       5.092           4.987 (3.572--6.961)     1.444 (1.034--2.017)    1.451 (1.039--2.027)    1.790 (0.661--4.849)    
  Age                                                                                                                                                                     
  \<50                All          225,584   604         2,891,255       0.208                                                                                            
  Normal              225,153      597       2,885,899   0.206           Ref                      Ref                     Ref                     Ref                     
  Mild                215          6         2,638       1.022           11.092 (4.963--24.788)   9.064 (4.053--20.269)   8.166 (3.648--18.278)   6.250 (1.553--25.152)   
  Severe              216          1         2,718       0.368           1.788 (0.251--12.715)    1.470 (0.207--10.458)   1.404 (0.197--9.988)    2.539 (0.356--18.090)   
  50--64              All          122,759   2,022       1,490,703       1.356                                                                                            
  Normal              122,007      1,977     1,482,544   1.334           Ref                      Ref                     Ref                     Ref                     
  Mild                319          22        3,310       6.646           5.089 (3.343--7.747)     3.407 (2.237--5.190)    2.946 (1.915--4.534)    3.459 (1.641--7.289)    
  Severe              433          23        4,848       4.744           3.594 (2.383--5.422)     2.269 (1.503--3.426)    2.263 (1.499--3.416)    2.550 (1.320--4.925)    
  ≥65                 All          166,336   4,691       1,190,170       3.941                                                                                            
  Normal              161,773      4,492     1,169,999   1.839           Ref                      Ref                     Ref                     Ref                     
  Mild                887          82        5,873       13.962          3.670 (2.950--4.566)     2.688 (2.159--3.346)    2.720 (2.185--3.386)    2.709 (1.756--4.178)    
  Severe              3,676        117       14,298      6.827           2.277 (1.895--2.735)     1.489 (1.238--1.791)    1.497 (1.245--1.801)    1.483 (1.057--2.081)    
  Health behavior                                                                                                                                                         
  Current smoker      All          112,900   1,997       1,287,632       1.549                                                                                            
  Normal              111,930      1,947     1,280,774   1.519           Ref                      Ref                     Ref                     Ref                     
  Mild                240          23        2,209       10.411          6.935 (4.597--10.462)    2.931 (1.941--4.425)    3.017 (1.998--4.556)    2.985 (1.687--5.281)    
  Severe              730          27        4,648       5.809           3.965 (2.711--5.797)     1.121 (0.765--1.642)    1.162 (0.793--1.702)    1.270 (0.761--2.120)    
  At-risk drinking    All          71,686    1,162       792,527         1.466                                                                                            
  Normal              71,221       1,128     788,186     1.431           Ref                      Ref                     Ref                     Ref                     
  Mild                140          11        1,367       8.049           5.719 (3.158--10.257)    2.430 (1.340--4.405)    2.473 (1.364--4.484)    2.610 (1.439--4.732)    
  Severe              325          23        2,976       7.730           5.546 (3.670--8.381)     1.592 (1.050--2.413)    1.653 (1.091--2.506)    1.526 (0.988--2.358)    
  Chronic disease                                                                                                                                                         
  Hypertension        All          287,221   5,668       2,953,874       1.919                                                                                            
  Normal              283,234      5,476     2,931,258   1.868           Ref                      Ref                     Ref                     Ref                     
  Mild                971          83        7,730       10.737          5.974 (4.810--7.421)     2.858 (2.300--3.553)    2.825 (2.274--3.516)    3.169 (2.098--4.787)    
  Severe              3,016        109       14,886      7.322           4.216 (3.487--5.096)     1.593 (1.317--1.928)    1.601 (1.323--1.938)    1.779 (1.282--2.469)    
  Diabetes mellitus   All          64,008    1,565       581,109         2.693                                                                                            
  Normal              62,743       1,504     574,888     2.616           Ref                      Ref                     Ref                     Ref                     
  Mild                346          30        2,485       12.070          4.812 (3.352--6.908)     3.390 (2.361--4.868)    3.280 (2.271--4.739)    2.951 (1.319--6.602)    
  Severe              919          31        3,736       8.298           3.071 (2.878--3.277)     1.725 (1.206--2.466)    1.697 (1.187--2.427)    2.450 (1.375--4.366)    
  Dyslipidemia        All          81,303    1,262       806,647         1.565                                                                                            
  Normal              80,253       1,228     801,370     1.532           Ref                      Ref                     Ref                     Ref                     
  Mild                231          16        1,851       8.644           5.819 (3.553--9.529)     2.640 (1.610--4.329)    2.631 (1.604--4.314)    3.146 (1.171--8.448)    
  Severe              819          18        3,427       5.253           3.745 (2.351--5.966)     1.541 (0.966--2.458)    1.583 (0.992--2.526)    0.984 (0.314--3.081)    

Model 1: sex and age

Model 2: Model 1 + hypertension, diabetes mellitus, and dyslipidemia

Model 3: Model 2 + BMI, cigarette smoking, and at-risk alcohol drinking

For subgroup analysis, we used the model without variable of stratification. For example, we used model 1 without sex in model 1 of subgroup analysis for sex

N/A: not applicable due to high missing rate, CI: confidence interval, PY: person-year, HR: hazard ratio

Subgroup analysis {#sec014}
-----------------

For current smokers, CV disease incidence was significantly increased in the severe disabled group in all Models, whereas CV mortality was increased only in the mild disabled group in all Models. At-risk drinkers with mild disability were more likely to have CV event in all Models. Similarly, at risk-drinkers with disability showed higher CV mortality, except for participants with severe disability, in Model 3.

Participants with hypertension or diabetes showed increased CV disease incidence when they had a disability in Models 1 and 2 but not in Model 3, while their mortality was significantly higher in all Models than that of participants without disability. Similarly, CV disease incidence was higher in participants with dyslipidemia in both mild and severe disability groups in Models 1 and 2, while only those with mild disability had higher CV incidence in Model 3. For CV mortality, participants with mild disability showed higher mortality in all Models when they had dyslipidemia.

Discussion {#sec015}
==========

To our knowledge, this is the first large general population study to evaluate the association of CV disease incidence and mortality with disability in the Asian population, using a nationwide representative claim database. Overall, CV disease incidence, CV mortality, and all-cause mortality increased in participants with disability regardless of type or severity of disability after full adjustment of CV risk factors. This finding showed that CV mortality increase in people with disability is not fully explained by their higher CV risk factors. Although CV mortality increased in all age groups, the increase was more evident in young participants. Although CV disease incidence and mortality were not significantly different in the subgroup analysis of health behavior in the fully adjusted model, CV mortality increase was observed in the subgroup analysis of participants with chronic diseases.

Several previous studies showed that mortality increased in people with physical frailty or disability. A systematic review of 19 studies evaluating the association of handgrip strength and gait speed with CV mortality also showed that decreased physical performance was associated with increased CV mortality \[[@pone.0236665.ref023]\]. In the study, they found that the association was independent of anthropometric features (i.e., BMI and height) and traditional CV risk factors (i.e., smoking and dyslipidemia). However, the studies included in the review used a limited definition of physical disability measured by handgrip strength or gait speed, and no large-scale long-term study was conducted in the Asian population.

A previous study on older adults aged ≥80 years showed that disability was more predictive of all-cause mortality than multimorbidity \[[@pone.0236665.ref026]\]. In the study, people with disability had 2.36 times more risk of mortality than those without disability or comorbidity, while people with multimorbidity had 1.66 times more risk of mortality. This finding indicated that disability itself contributed to mortality in the study population regardless of comorbidities in people with disability. Similarly, we found that CV disease incidence and mortality increased after controlling chronic diseases (i.e., Model 2), and subgroup analyses of chronic diseases showed the same results. Based on these results, we assumed that disability is among the risk factors for CV regardless of chronic diseases, which are known traditional risk factors for CV.

The current study showed that CV mortality increased only in men in the fully adjusted model (i.e., Model 3). This finding suggests that there is discrepancy between sexes in terms of the effect of disability on CV mortality. A similar finding was reported in a Finnish study of 4,501 men and women aged ≥45 years, which showed that disability was predictive of mortality only in men not in women with coronary heart disease (CHD) \[[@pone.0236665.ref030]\]. In the study, the incidence of coronary heart disease-related death increased 1.3--1.5 times in men and women, except in women with a history of CHD, which indicates that risk factors for CV disease differ between men and women. This discrepancy is possibly explained by differences in sex hormone, which influences CV risk and physical performance in different ways in both sexes \[[@pone.0236665.ref031]--[@pone.0236665.ref033]\].

We found that the effect of disability on CV disease incidence and mortality was not necessarily greater in older participants. CV mortality was six times higher in participants aged \<50 years with mild disability, while it was less than four times in those aged ≥50 years. Although this study showed that disability was a risk factor for CV disease independent of conventional risk factors, our finding suggests that the effect of disability on CV disease is diluted when participants have more conventional CV risk factors, which are far more prevalent in older adults.

There are several limitations in this study. There is a limitation in the database, which prevented the adjustment for well-known CV risk factors such as education and dietary intake. Moreover, the database did not include data on the severity of CV disease; therefore, the models cannot be adjusted for severity of the disease. Furthermore, we collected data on health behaviors using a questionnaire; thus, it is possible that there is recall bias in those data. We did not include physical activity as a covariate due to the large amount of missing information in the database, which is an important health behavior for CV disease prevention. Additionally, because NHID is a medical claims database, it is possible that the diagnoses of CV disease and cause of death were misclassified. However, all claims in this dataset were audited by the Korean Health Insurance Review and Assessment before payment, making the misclassification of diagnosis improbable.

In conclusion, people with disability showed higher CV disease incidence and mortality than those without disability, regardless of the type of disability or risk factors for CV disease.

This study used customized research database of the Korean National Health Insurance Service (NHIS-2019-2-213) made by KNHIS.
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